Denosumab delays development of prostate cancer bone metastasis (EurekAlert, 15 November 2011)

16 Nov 2011


An international study published in The Lancet suggests that the bone microenvironment may be a viable target to prevent the development of prostate cancer metastasis.

Full article


Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story